Detecting the Effect of Umckaloabo/EPs®7630 Liquid Extract after its Therapeutic Purposed Usage in Calves Showing Symptoms of Respiratory Tract Infection

Authors

  • Ahmet Ak Department of Virology, Faculty of Veterinary Medicine, Mehmet Akif Ersoy University, Burdur, Turkey.
  • Mehmet Kale Department of Virology, Faculty of Veterinary Medicine, Mehmet Akif Ersoy University, Burdur, Turkey.

DOI:

https://doi.org/10.22456/1679-9216.80475

Keywords:

respiratory infection, BRSV, Umckaloabo/ EPs®7630, Pelargonium sidoides, calf.

Abstract

Background: Respiratory tract diseases are commonly seen in beef cattle. Young calves are affected with many respiratory pathogens. Viral pathogens are particularly seen. There are many causative factors, e.g. environmental conditions, immune system of calves. Therefore, alternative treatments are needed for viral respiratory infections. The purpose of the current study was to investigate effectiveness of Umckaloabo/EPs®7630 liquid extract in some bovine viral pathogens of young beef calves.

Materials, Methods & Results: Antibody presence in terms of bovine herpesvirus type 1 (BHV-1), bovine viral diarrhea virus (BVDV), bovine parainfluenza virus type 3 (BPIV-3), bovine respiratory syncytial virus (BRSV) and bovine adenovirus type 3 (BAV-3) was searched in blood serum samples of 40 Holstein calves aged 6 months and over showing respiratory tract infection symptoms. All animals were found seronegative in terms of other factors except BRSV. Out of 20 BRSV seropositive calves, 10 of them were classified as control group and the other ten as testing group. BRSV antibody titers were also detected in blood samples of both groups on day 0. Umckaloabo/EPs®7630 liquid extract was given through oral route to animals in testing group according to their weights for 14 days morning, noon and night. No application was performed on animals in control group. BRSV antibody titers were detected in blood samples of animals in both groups taken on days 1st, 3rd, 5th, 7th, 10th and 14th. At the end of day 14th, BRSV antibody titer increased in 9 out of 10 animals (90%) in testing group that were given Umckaloabo/EPs® 7630 liquid extract while one of them (10%) showed no variability. BRSV antibody titer increased in 6 out of 10 animals (60%) in control group while it decreased in one of them (10%) and 3 of them (30%) showed no variability. In testing group, BRSV antibody titer started to increase on day 3rd in 6 out of 10 animals (60%), on day 5th in one (10%), on day 10th in one (10%) and on day 14th in another (10%). In control group, BRSV antibody titer started to increase on day 3rd in 3 out of 10 animals (30%) and on day 5th in 3 of them (30%). When haematologic values of blood samples taken from animals in testing and control groups on day 14th were studied comparatively, no statistical importance (P < 0.01 or P < 0.05) and difference was detected. As a result, in stock calves showing respiratory tract infection symptoms, applying Umckaloabo/EPs® 7630 liquid extract helped BRSV antibody titer to increase and symptoms decreased. The increase in antibody titers started from day 3rd especially after applying Umckaloabo/EPs® 7630 liquid extract.

Discussion: Respiratory system infections are contagious and fatal in calves. Respiratory tract bacterial and viral vaccinations are applied in order to prevent losses of calves due to these problems. However, these vaccinations are not sufficient most of the time and antibiotics+supportive treatment applications follow afterwards. Therefore, we advise to use a herbal product, Umckaloabo/ EPs®7630 liquid extract, that has both an antiviral efficiency and a feature of supporting immune system in order to prevent mortalities in stock calves, to stop the infection from spreading on all the herd and to decrease the symptoms of respiratory system. We believe that the obtained data should be supported with more examples and more wide-ranging studies.

Downloads

Download data is not yet available.

References

Agbabiaka T.B., Guo R. & Ernst E. 2008. Pelargonium sidoides for acute bronchitis: a systematic review and metaanalysis. Phytomedicine. 15(5): 378-385.

Balbani A.P.S., Montovani J.C. & Carvalho L.R. 2009. Pharyngotonsillitis in children: view from a sample of pediatricians and otorhinolaryngologists. Brazilian Journal of Otorhinolaryngology. 75(1): 139-146.

Bao Y., Gao Y., Koch E., Pana X., Jina Y. & Cui X. 2015. Evaluation of pharmacodynamic activities of EPsR 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis. Phytomedicine. 22(4): 504-509.

Brendler T. 2009. Umckaloabo: From a Patent Remedy to a Modern Herbal Pharmaceutical Based on Pelargonium sidoides with Clinically Proven Efficacy. In: Juliani R.H., Simon J.H. & Ho C.T. (Eds). African Natural Plant Products: New discoveries and Challenges in Chemistry and Quality. Oxford: Oxford University Press, pp.295-319.

Bryson D.G., McFerran J.B., Ball H.J. & Neill S.D. 1978. Observations on outbreaks of respiratory disease in housed calves. Epidemiological and clinical findings. The Veterinary Record. 103(22): 485-489.

Chuchalin A.G., Berman B. & Lehmacher W. 2005. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs® 7630): A randomized, double-blind, placebo-controlled trial. Explore (NY). 1(6): 437-445.

Conrad A., Hansmann C., Engels I., Daschner F.D. & Frank U. 2007. Extract of Pelargonium sidoides (EPs® 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine. 14(6): 46-51.

Elvander M. 1996. Severe respiratory disease in dairy cows caused by infection with bovine respiratory syncytial virus. The Veterinary Record. 138(5): 101-105.

Gezer A. & Turan F. 2009. Sardunya kökü (Pelargonium sidoides) ekstraktının yavru sazan (Cyprinus carpio l. 1758)’larda büyüme, vücut kompozisyonu ve kan parametreleri üzerine etkileri. 54syf. Hatay, Yüksek lisans tezi (Su Ürünleri Fakültesi)-Su Ürünleri Anabilim Dalı Programı, Mustafa Kemal Üniversitesi.

Helfer M., Koppensteiner H., Schneider M., Rebensburg S., Forcisi S., Muller C., Schmitt-Kopplin P., Schindler M. & Brack-Werner R. 2014. The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor. PLOS ONE. 9(1): e.87487- 87487.

Kolodziej H. 2007. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo. Phytomedicine. 14(6): 9-17.

Lin L.T., Hsu W.C. & Lin C.C. 2014. Antiviral natural products and herbal medicines. Journal of Traditional and Complementary Medicine. 4(1): 24-35.

Luna L.A., Bachib A.L.L., Novaes e Brito R.R., Eid R.G., Suguri V.M., Oliveira P.W., Gregorio L.C. & Vaisberg M. 2011. Immune responses induced by Pelargonium sidoides extract in serum and nasal mucosa of athletes after exhaustive exercise: modulation of secretory IgA, IL-6 and IL-15. Phytomedicine. 18(4): 303-308.

Matthys H. & Heger M. 2007. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs® 7630): a randomised, double-blind, placebo-controlled, multicentre study. Current Medical Research Opinion. 23(2): 323-331.

Michaelis M., Doerr H.W. & Cinatl J. 2011. Investigation of the influence of EPs 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 18(5): 384-386.

Neugebauer P., Mickenhagen A., Siefer O. & Walger M. 2005. A new approach to pharmacological effects of ciliary beat frequency in cell cultures-exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine. 12(1-2): 46-51.

Schnitzler P., Schneider S., Stintzing F.C., Carle R. & Reichling J. 2008. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus. Phytomedicine. 15(12): 1108-1116.

Schulz V. 2007. Liquid herbal drug preparation from the root of Pelargonium sidoides is effective against acute bronchitis: Results of a double-blind study with 124 patients. Phytomedicine. 14(6): 74-75.

Sharp M.W., Williams R.L. & Munro R. 1993. Acute respiratory distress syndrome in yearling cattle. The Veterinary Record. 132(18): 467-468.

Stott E.J., Thomas L.H., Collins A.P., Crough S., Jebbet J., Smıth G.S., Luther P.D. & Caswell R. 1980. A survey of virus infections of the respiratory tract of cattle and their association with disease. The Journal of Hygiene. 85(2): 257-270.

Tahan F. & Yaman M. 2013. Can the Pelargonium sidoides root extract EPs 7630 prevent asthma attacks during viral infections of the upper respiratory tractin children? Phytomedicine. 20(2): 148-150.

Theisen L.L. & Muller C.P. 2012. EPs 7630 (umckaloabo), an extract from Pelargonium sidoides roots, exerts antiinfluenza virus activity in vitro and in vivo. Antiviral Research. 94(2): 147-156.

Tunc A. & Patıroglu T. 2010. Süt çocuğunun geçici hipogammaglobulinemisi olan hastalarda üst solunum yolu enfeksiyonu tedavisinde Pelargonium sidoides etkinliğinin değerlendirilmesi. 67syf. Kayseri, Yüksek lisans tezi (Tıp Fakültesi)-Çocuk Sağlığı ve Hastalıkları Anabilim Dalı Programı, Erciyes Üniversitesi.

Valarcher J.F. & Hagglund S. 2006. Viral respiratory infections in cattle. In: XXIV. World Buiatrics Congress (Nice, France). Available at:< http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.500.5102&rep=rep1&type=pdf>. [Accessed online in September 2016].

Poel van der W.H.M., Kramps J.A., Middel W.G.J., Oirschot van J.T. & Brand A. 1993. Dynamics of bovine respiratory syncytial virus: A longitudinal epidemiological study in dairy herds. Archives of Virology. 133(3-4): 309-321.

Poel van der W.H.M., Brand A., Kramps J.A. & Oirschot van J.T. 1994. Respiratory syncytial virs infections in human beings and in cattle, an epidemiological review. Journal of Infection. 29(2): 215-228.

Walpole S.C., Prieto-Merino D., Edwards P., Cleland J., Stevens G. & Roberts I. 2012. The weight of nations: an estimation of adult human biomass. BMC Public Health. 12(439): 1-6.

Westenbrink F. & Kimman T.G. 1987. Immunoglobulin M-specific enzyme-linked immunosorbent assay for serodia gnosis of bovine respiratory syncytial virus infections. American Journal of Veterinary Reserach. 48(7): 1132-1137.

Published

2017-01-01

How to Cite

Ak, A., & Kale, M. (2017). Detecting the Effect of Umckaloabo/EPs®7630 Liquid Extract after its Therapeutic Purposed Usage in Calves Showing Symptoms of Respiratory Tract Infection. Acta Scientiae Veterinariae, 45(1), 10. https://doi.org/10.22456/1679-9216.80475

Issue

Section

Articles

Most read articles by the same author(s)